Clinical trial

Efficacy of Thyme Honey in The Management of Oral Aphthous Ulcers: A Randomized Controlled Clinical Trial

Name
24-031
Description
Recurrent aphthous stomatitis (RAS) is considered the most common oral mucosal lesion, present first in childhood or adolescence. Aphthous ulcers affect up to 25% of the general population, and 3-month recurrence rates are as high as 50%, it is more common in female, also it increases by increasing age and minor aphthous ulcers are 80% of suffered patient. Due to the antimicrobial, anti-inflammatory, antifungal, and analgesic effects of Thyme honey, and the lack of evidence in the considered population, the present study aimed to assess the effect of honey on the pain relief in patients with minor RAU as a primary objective and to assess the healing effect of natural thyme honey on minor RAU, and the Oral Health Impact Profile (OHIP-14) as a secondary objectives.
Trial arms
Trial start
2024-05-10
Estimated PCD
2024-05-15
Trial end
2024-05-30
Status
Not yet recruiting
Treatment
Thyme honey
Thyme honey is a rich monofloral honey variety formed by bees that collect nectar from thymus vulgaris flowers. thyme honey application (100% pure natural honey, applied by themselves) on their ulcers three times a day for 7 days
Arms:
Thyme honey
Kenalog
kenalog in orabase (Triamcinolone acetonide 0.1% in oral paste 5g)
Arms:
kenalog in orabase
Other names:
kenalog in orabase
Size
20
Primary endpoint
Pain intensity
7 days.
Eligibility criteria
Inclusion Criteria: * • The study involved patients who had a positive history of having similar oral mucosal ulcers for 3-4 months and ulcers for \<48 h. * Clinically diagnosed patients with chronic aphthous stomatitis measuring ≤5 mm in size in the oral cavity and who gave written consent for participation. * Only single ulcers were considered for the study. * Systemically health patients. Exclusion Criteria: * The study excluded patients with a history of associated systemic disease. * Cases of chronic aphthous stomatitis (major), lesions of herpetic form, numerous RAS lesions, and smoking. * In addition, no consideration was given to patients with a history of hypersensitivity to honey.
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'interventionModelDescription': 'Thyme honey on recurrent aphthous stomatitis', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'DOUBLE', 'maskingDescription': 'the care provider and the outcomes assessor will not know which treatment will be given to the patients.', 'whoMasked': ['CARE_PROVIDER', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 20, 'type': 'ESTIMATED'}}
Updated at
2024-05-20

1 organization

1 product

2 indications

Product
Kenalog